Download Full Text (7.1 MB)


  • Finding a Way Forward in Parathyroid Carcinoma: Among the rarest of the rare malignancies, parathyroid carcinoma poses myriad diagnostic and treatment challenges. Owing to its extreme rarity, very little is known about the mechanisms driving parathyroid carcinoma, let alone how to target them; and survival rates have not budged in decades. However researchers at The University of Texas MD Anderson Cancer Center are working to change this.
  • Studies Explore Screening for HPV-related Anal and Oropharyngeal Cancers: No consensus screening guidelines exist for human papillomavirus (HPV)-related cancers other than cervical cancer. As a step toward establishing such guidelines, studies under way or in the planning stages at The University of Texas MD Anderson Cancer Center will test various strategies for early detection of specific HPV-related cancers in populations believed to be at high risk.
  • HOUSE CALL: What You Should Know About Drug Advertisements-Prescription drug ads may not tell the whole story.

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Perrier, Nancy; Busaidy, Naifa; Williams, Michelle; Vauthey, Jean-Nicolas; Vaporciyan, Ara; Silva, Angelica; Sturgis, Erich M.; Schmeler, Kathleen; Messick, Craig; Hwang, Jessica; Parathyroid Neoplasms; Clinical Trials as Topic; Biomarkers, Tumor; Genetic Profile; Human Papillomavirus Viruses; Anus Neoplasms; Oropharyngeal Neoplasms; Direct-to-Consumer Advertising; Human Papillomavirus DNA Tests.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 61, Number 08, August 2016